Global Favipiravir Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Favipiravir market size will reach Million USD in 2025 and is projected to reach Million USD by 2032, with a CAGR of % (2025-2032). Notably, the China Favipiravir market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Favipiravir is an antiviral medication used in the treatment of certain viral infections. It belongs to a class of drugs known as nucleoside analogs, which work by interfering with the replication and transcription of viral genetic material, inhibiting the spread of the virus within the body. Favipiravir gained attention during the COVID-19 pandemic as a potential treatment option, although its effectiveness in treating the virus remains a subject of ongoing research and clinical trials. In addition to its potential use for COVID-19, favipiravir has been approved for the treatment of influenza in some countries and is being investigated for its antiviral properties against other viral infections. Its use should be supervised by healthcare professionals, as it may have side effects and drug interactions that need to be carefully managed.
The major global suppliers of Favipiravir include ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma, Cipla, Lupin, Hisun Pharm, Sun Pharma, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Favipiravir. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Favipiravir market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Favipiravir market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Favipiravir industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Favipiravir Include:
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Cipla
Lupin
Hisun Pharm
Sun Pharma
Favipiravir Product Segment Include:
Brand Drug
Generic Drug
Favipiravir Product Application Include:
Influenza Viruses
COVID-19
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Favipiravir Industry PESTEL Analysis
Chapter 3: Global Favipiravir Industry Porter's Five Forces Analysis
Chapter 4: Global Favipiravir Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Favipiravir Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Favipiravir Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Favipiravir Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Favipiravir market size will reach Million USD in 2025 and is projected to reach Million USD by 2032, with a CAGR of % (2025-2032). Notably, the China Favipiravir market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Favipiravir is an antiviral medication used in the treatment of certain viral infections. It belongs to a class of drugs known as nucleoside analogs, which work by interfering with the replication and transcription of viral genetic material, inhibiting the spread of the virus within the body. Favipiravir gained attention during the COVID-19 pandemic as a potential treatment option, although its effectiveness in treating the virus remains a subject of ongoing research and clinical trials. In addition to its potential use for COVID-19, favipiravir has been approved for the treatment of influenza in some countries and is being investigated for its antiviral properties against other viral infections. Its use should be supervised by healthcare professionals, as it may have side effects and drug interactions that need to be carefully managed.
The major global suppliers of Favipiravir include ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma, Cipla, Lupin, Hisun Pharm, Sun Pharma, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Favipiravir. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Favipiravir market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Favipiravir market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Favipiravir industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Favipiravir Include:
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Cipla
Lupin
Hisun Pharm
Sun Pharma
Favipiravir Product Segment Include:
Brand Drug
Generic Drug
Favipiravir Product Application Include:
Influenza Viruses
COVID-19
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Favipiravir Industry PESTEL Analysis
Chapter 3: Global Favipiravir Industry Porter's Five Forces Analysis
Chapter 4: Global Favipiravir Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Favipiravir Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Favipiravir Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Favipiravir Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Favipiravir Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Favipiravir Product by Type
- 1.2.1 Brand Drug
- 1.2.2 Generic Drug
- 1.3 Favipiravir Product by Application
- 1.3.1 Influenza Viruses
- 1.3.2 COVID-19
- 1.3.3 Others
- 1.4 Global Favipiravir Market Size Analysis (2020-2032)
- 1.5 Favipiravir Market Development Status and Trends
- 1.5.1 Favipiravir Industry Development Status Analysis
- 1.5.2 Favipiravir Industry Development Trends Analysis
- 2 Favipiravir Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Favipiravir Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Favipiravir Market Analysis by Country
- 4.1 Global Favipiravir Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Favipiravir Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Favipiravir Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Favipiravir Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Favipiravir Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Favipiravir Market Revenue and Growth Rate (2020-2032)
- 4.5 China Favipiravir Market Revenue and Growth Rate (2020-2032)
- 4.6 France Favipiravir Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Favipiravir Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Favipiravir Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Favipiravir Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Favipiravir Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Favipiravir Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Favipiravir Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Favipiravir Market Revenue and Growth Rate (2020-2032)
- 4.14 India Favipiravir Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Favipiravir Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Favipiravir Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Favipiravir Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Favipiravir Market Revenue by Key Suppliers (2021-2025)
- 5.2 Favipiravir Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Favipiravir Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Favipiravir Market Analysis by Type
- 6.1 Global Favipiravir Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Favipiravir Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 ChemRar Group
- 7.1.1 ChemRar Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 ChemRar Group Favipiravir Product Portfolio
- 7.1.3 ChemRar Group Favipiravir Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Glenmark
- 7.2.1 Glenmark Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Glenmark Favipiravir Product Portfolio
- 7.2.3 Glenmark Favipiravir Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Fujifilm
- 7.3.1 Fujifilm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Fujifilm Favipiravir Product Portfolio
- 7.3.3 Fujifilm Favipiravir Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Dr. Reddy
- 7.4.1 Dr. Reddy Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Dr. Reddy Favipiravir Product Portfolio
- 7.4.3 Dr. Reddy Favipiravir Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 R-Pharma
- 7.5.1 R-Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 R-Pharma Favipiravir Product Portfolio
- 7.5.3 R-Pharma Favipiravir Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Cipla
- 7.6.1 Cipla Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Cipla Favipiravir Product Portfolio
- 7.6.3 Cipla Favipiravir Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Lupin
- 7.7.1 Lupin Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Lupin Favipiravir Product Portfolio
- 7.7.3 Lupin Favipiravir Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Hisun Pharm
- 7.8.1 Hisun Pharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Hisun Pharm Favipiravir Product Portfolio
- 7.8.3 Hisun Pharm Favipiravir Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Sun Pharma
- 7.9.1 Sun Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Sun Pharma Favipiravir Product Portfolio
- 7.9.3 Sun Pharma Favipiravir Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Favipiravir Industry Chain Analysis
- 8.2 Favipiravir Product Downstream Application Analysis
- 8.2.1 Global Favipiravir Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Favipiravir Revenue and Forecast by Application (2020-2032)
- 8.3 Favipiravir Typical Downstream Customers
- 8.4 Favipiravir Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
